It is a pharma private limited company based in Pune, Maharashtra, India, established in 2010.
2010 | Pune, Maharashtra, India | ActiveAccela Pharmaceuticals Private Limited, a active private limited company, was established on 05 July 2010 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24232PN2010PTC136759. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Pragati Dinesh Bothara (Director), Dinesh Keshari Chand Bothra (Director). Past directors included Dineshchand Hirachand Munot, Viraj Dhirubhai Shah, Pragati Dinesh Bothara. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at S No. 118 To 124, Plot No 98, National Soc, Aundh,, Pune, Maharashtra, 411021.
U24232PN2010PTC136759
136759
05 July 2010
₹0.50 M
₹0.15 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Accela Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pragati Dinesh Bothara | Director | 30 Mar 2022 | Current |
| Dinesh Keshari Chand Bothra | Director | 05 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2015 | Past |
| Pramod Abcsdd | Director | 19 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 16 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Accela Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.03% decrease. The company also saw a substantial fall in profitability, with a 34.57% decrease in profit. The company's net worth Soared by an impressive increase of 16.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Accela Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Accela Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Accela Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accela Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Accela Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Accela Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Pragati Dinesh Bothara was appointed as a Director was appointed as a Director on 30 Mar 2022 & has been associated with this company since 3 years 9 months . was recorded as a recent event.
The activity Dinesh Keshari Chand Bothra was appointed as a Director was appointed as a Director on 05 Jul 2010 & has been associated with this company since 15 years 6 months . was completed.
Progress on Accela Pharmaceuticals Private Limited was registered on 05 Jul 2010 with Roc Pune & aged 15 years 6 months as per MCA records. was documented.
The CIN of Accela Pharmaceuticals Private Limited is U24232PN2010PTC136759.
Accela Pharmaceuticals Private Limited is headquartered at S No. 118 To 124, Plot No 98, National Soc, Aundh,, Pune, Maharashtra, 411021.
Accela Pharmaceuticals Private Limited was incorporated on 05 July 2010.
The current directors of Accela Pharmaceuticals Private Limited are
The primary industry of Accela Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Accela Pharmaceuticals Private Limited is unlisted.
The authorized capital of Accela Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.
The compliance status of Accela Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX